Phathom Pharmaceuticals Inc (PHAT)
10.27
-0.13
(-1.25%)
USD |
NASDAQ |
Jun 28, 16:00
10.31
+0.04
(+0.39%)
After-Hours: 20:00
Phathom Pharmaceuticals Cash from Operations (Quarterly): -69.02M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -69.02M |
| December 31, 2023 | -43.80M |
| September 30, 2023 | -31.91M |
| June 30, 2023 | -22.20M |
| March 31, 2023 | -39.67M |
| December 31, 2022 | -41.04M |
| September 30, 2022 | -35.02M |
| June 30, 2022 | -25.72M |
| March 31, 2022 | -44.76M |
| December 31, 2021 | -41.26M |
| September 30, 2021 | -29.07M |
| Date | Value |
|---|---|
| June 30, 2021 | -28.36M |
| March 31, 2021 | -49.76M |
| December 31, 2020 | -28.20M |
| September 30, 2020 | -20.73M |
| June 30, 2020 | -9.344M |
| March 31, 2020 | -11.42M |
| December 31, 2019 | -23.38M |
| September 30, 2019 | -7.108M |
| June 30, 2019 | -5.211M |
| March 31, 2019 | -0.807M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-69.02M
Minimum
Mar 2024
-5.211M
Maximum
Jun 2019
-30.35M
Average
-28.72M
Median
Cash from Operations (Quarterly) Benchmarks
| Insmed Inc | -184.04M |
| Regeneron Pharmaceuticals Inc | 1.512B |
| Rocket Pharmaceuticals Inc | -56.86M |
| Rhythm Pharmaceuticals Inc | -40.74M |
| Biomea Fusion Inc | -32.03M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.04M |
| Cash from Financing (Quarterly) | 9.90M |
| Free Cash Flow | -168.39M |
| Free Cash Flow Per Share (Quarterly) | -1.183 |
| Free Cash Flow to Equity (Quarterly) | -80.24M |
| Free Cash Flow Yield | -29.67% |